Collins James J. — SEC Form 4 filings

SEC reporting owner CIK 1779269. 4 Form 4 filings on record with FilingPulse; latest filed 2025-06-27.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-06-18 to 2025-06-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Senti Biosciences, Inc. (SNTI)Director33
Fulcrum Therapeutics, Inc. (FULC)Director11

Form 4 filings — Collins James J.

FiledFormIssuerReported transactionsSource
2025-06-274Senti Biosciences, Inc. (SNTI)Grant/award (A): 21,950 (derivative) @ $0EDGAR
2025-03-114Senti Biosciences, Inc. (SNTI)Grant/award (A): 43,900 (derivative) @ $0EDGAR
2024-07-124Senti Biosciences, Inc. (SNTI)Grant/award (A): 62,500 (derivative) @ $0EDGAR
2024-06-184Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 30,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1779269 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →